Ropes & Gray advised Patient Square Capital as regulatory counsel in completing the acquisition of Premier, Inc. in a take-private deal valued at $2.6 billion. In connection with the transaction, Premier common stock ceased trading and will be delisted from Nasdaq as of November 25, 2025. Premier stockholders will receive $28.25 in cash per share.
Patient Square Capital is an investment firm that partners with growth oriented companies whose products, services and technologies improve health.
Premier Inc. is a leading technology-driven health care company that provides data, analytics, consulting and supply chain solutions for health care provides, suppliers, payers and policymakers.
The Ropes & Gray team included health care partners Christina Bergeron and Eve Brunts, life sciences regulatory & compliance partner Josh Oyster, health care associate Gideon Palte and life sciences regulatory & compliance associate Michael Purcell.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.